Explained: Kerala's switch to a cheaper SMA drug sparks debate

Kerala's decision to move children with spinal muscular atrophy onto a cheaper generic medicine has triggered debate among parents and lawmakers over safety, effectiveness and labelling. SMA is a rare, life-threatening genetic disorder that steadily weakens muscles and affects movement and breathing. The controversy centres on whether the switch was handled transparently.